193 related articles for article (PubMed ID: 36674751)
41. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults.
Stättermayer AF; Halilbasic E; Wrba F; Ferenci P; Trauner M
J Hepatol; 2020 Sep; 73(3):651-663. PubMed ID: 32376413
[TBL] [Abstract][Full Text] [Related]
42. Clinical and genetic study of ABCB4 gene-related cholestatic liver disease in China: children and adults.
Cao L; Ling X; Yan J; Feng D; Dong Y; Xu Z; Wang F; Zhu S; Gao Y; Cao Z; Zhang M
Orphanet J Rare Dis; 2024 Apr; 19(1):157. PubMed ID: 38610052
[TBL] [Abstract][Full Text] [Related]
43. Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity.
Groen A; Romero MR; Kunne C; Hoosdally SJ; Dixon PH; Wooding C; Williamson C; Seppen J; Van den Oever K; Mok KS; Paulusma CC; Linton KJ; Oude Elferink RP
Gastroenterology; 2011 Nov; 141(5):1927-37.e1-4. PubMed ID: 21820390
[TBL] [Abstract][Full Text] [Related]
44. Thyroid hormone receptor β1 stimulates
Gautherot J; Claudel T; Cuperus F; Fuchs CD; Falguières T; Trauner M
J Lipid Res; 2018 Sep; 59(9):1610-1619. PubMed ID: 29895698
[TBL] [Abstract][Full Text] [Related]
45. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
[TBL] [Abstract][Full Text] [Related]
46. Progressive familial intrahepatic cholestasis.
Srivastava A
J Clin Exp Hepatol; 2014 Mar; 4(1):25-36. PubMed ID: 25755532
[TBL] [Abstract][Full Text] [Related]
47. Case series of progressive familial intrahepatic cholestasis type 3: Characterization of variants in
Cheng J; Gong L; Mi X; Wu X; Zheng J; Yang W
Front Med (Lausanne); 2022; 9():962408. PubMed ID: 36569137
[TBL] [Abstract][Full Text] [Related]
48. A mutation within the extended X loop abolished substrate-induced ATPase activity of the human liver ATP-binding cassette (ABC) transporter MDR3.
Kluth M; Stindt J; Dröge C; Linnemann D; Kubitz R; Schmitt L
J Biol Chem; 2015 Feb; 290(8):4896-4907. PubMed ID: 25533467
[TBL] [Abstract][Full Text] [Related]
49. Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy.
van der Woerd WL; van Mil SW; Stapelbroek JM; Klomp LW; van de Graaf SF; Houwen RH
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):541-53. PubMed ID: 20955958
[TBL] [Abstract][Full Text] [Related]
50. Gene therapy for progressive familial intrahepatic cholestasis type 3 in a clinically relevant mouse model.
Weber ND; Odriozola L; Martínez-García J; Ferrer V; Douar A; Bénichou B; González-Aseguinolaza G; Smerdou C
Nat Commun; 2019 Dec; 10(1):5694. PubMed ID: 31836711
[TBL] [Abstract][Full Text] [Related]
51. Chinese children with chronic intrahepatic cholestasis and high γ-glutamyl transpeptidase: clinical features and association with ABCB4 mutations.
Fang LJ; Wang XH; Knisely AS; Yu H; Lu Y; Liu LY; Wang JS
J Pediatr Gastroenterol Nutr; 2012 Aug; 55(2):150-6. PubMed ID: 22343912
[TBL] [Abstract][Full Text] [Related]
52. Dietary lecithin protects against cholestatic liver disease in cholic acid-fed Abcb4- deficient mice.
Lamireau T; Bouchard G; Yousef IM; Clouzeau-Girard H; Rosenbaum J; Desmoulière A; Tuchweber B
Pediatr Res; 2007 Feb; 61(2):185-90. PubMed ID: 17237720
[TBL] [Abstract][Full Text] [Related]
53. Heterozygous mutations of ATP8B1, ABCB11 and ABCB4 cause mild forms of Progressive Familial Intrahepatic Cholestasis in a pediatric cohort.
Mínguez Rodríguez B; Molera Busoms C; Martorell Sampol L; García Romero R; Colomé Rivero G; Martín de Carpi J
Gastroenterol Hepatol; 2022 Oct; 45(8):585-592. PubMed ID: 34942279
[TBL] [Abstract][Full Text] [Related]
54. Familial intrahepatic cholestasis: New and wide perspectives.
Vitale G; Gitto S; Vukotic R; Raimondi F; Andreone P
Dig Liver Dis; 2019 Jul; 51(7):922-933. PubMed ID: 31105019
[TBL] [Abstract][Full Text] [Related]
55. Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4.
Andress EJ; Nicolaou M; Romero MR; Naik S; Dixon PH; Williamson C; Linton KJ
Hepatology; 2014 May; 59(5):1921-31. PubMed ID: 24806754
[TBL] [Abstract][Full Text] [Related]
56. ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population.
Anzivino C; Odoardi MR; Meschiari E; Baldelli E; Facchinetti F; Neri I; Ruggiero G; Zampino R; Bertolotti M; Loria P; Carulli L
Dig Liver Dis; 2013 Mar; 45(3):226-32. PubMed ID: 23022423
[TBL] [Abstract][Full Text] [Related]
57. A novel etiologic factor of highly elevated cholestanol levels: progressive familial intrahepatic cholestasis.
Küçükçongar Yavaş A; Çavdarlı B; Ünal Uzun Ö; Uncuoğlu A; Gündüz M
J Pediatr Endocrinol Metab; 2020 May; 33(5):665-669. PubMed ID: 32229667
[TBL] [Abstract][Full Text] [Related]
58. ABCB4 Mutations in Adults Cause a Spectrum Cholestatic Disorder Histologically Distinct from Other Biliary Disease.
Sinha A; Bhuva M; Grant C; Gimson AE; Thompson E; Duckworth A; Davies SE; Aithal G; Griffiths WJ
Dig Dis Sci; 2022 Dec; 67(12):5551-5561. PubMed ID: 35288833
[TBL] [Abstract][Full Text] [Related]
59. Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing.
Vitale G; Gitto S; Raimondi F; Mattiaccio A; Mantovani V; Vukotic R; D'Errico A; Seri M; Russell RB; Andreone P
J Gastroenterol; 2018 Aug; 53(8):945-958. PubMed ID: 29238877
[TBL] [Abstract][Full Text] [Related]
60. Reversal of advanced fibrosis after long-term ursodeoxycholic acid therapy in a patient with residual expression of MDR3.
Frider B; Castillo A; Gordo-Gilart R; Bruno A; Amante M; Alvarez L; Mathet V
Ann Hepatol; 2015; 14(5):745-51. PubMed ID: 26256905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]